Shareholders approve all four proposals at Insight Molecular Diagnostics 2025 annual meeting

Insight Molecular Diagnostics Inc.

73.46% quorum achieved; all four director nominees (Riggs, Arno, Last, Silverman) elected.
Ratified CBIZ CPAs P.C. as independent auditor for FY 2025 with 20,986,994 votes for.
Non-binding say-on-pay proposal approved with 18,063,639 votes for.
Amendment to 2018 Equity Incentive Plan approved; shares authorized increased by 1,500,000 to 3,800,000.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.